These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27433817)

  • 1. Revisiting the structural basis and energetic landscape of susceptibility difference between HLA isotypes to allergic rhinitis.
    Mao XL; Zhu F; Pan ZH; Wu GM; Zhu HY
    Comput Biol Chem; 2016 Oct; 64():210-216. PubMed ID: 27433817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
    Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
    Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
    Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
    J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide binding predictions for HLA DR, DP and DQ molecules.
    Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
    BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
    Nepom BS; Nepom GT; Coleman M; Kwok WW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
    El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A; Lias M; Conger N
    Clin Transpl; 2009; ():295-321. PubMed ID: 20524293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients.
    Sánchez-Velasco P; Antón E; Muñoz D; Martínez-Quesada J; Ruíz de Alegría C; López-Hoyos M; García-Martín A; Jiménez I; Alonso ST; Duque S; Suárez A; Jerez J; Leyva-Cobián F
    Hum Immunol; 2005 Jul; 66(7):818-25. PubMed ID: 16112029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.
    McKinney DM; Southwood S; Hinz D; Oseroff C; Arlehamn CS; Schulten V; Taplitz R; Broide D; Hanekom WA; Scriba TJ; Wood R; Alam R; Peters B; Sidney J; Sette A
    Immunogenetics; 2013 May; 65(5):357-70. PubMed ID: 23392739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
    Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
    Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
    Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
    J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
    Jucaud V
    J Immunol Res; 2017; 2017():2748614. PubMed ID: 28331856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
    Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
    Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
    Shen WJ; Zhang X; Zhang S; Liu C; Cui W
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein.
    Ruiter B; Rozemuller EH; van Dijk AJ; Garssen J; Bruijnzeel-Koomen CA; Tilanus MG; Knol EF; van Hoffen E
    Int Arch Allergy Immunol; 2007; 143(2):119-26. PubMed ID: 17228168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.